SENS News and Press, Senseonics Holdings Inc. From 04/18/23

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the first pediatric study participant has been inserted with E...

2023-04-06 17:02:12 ET The FDA on Thursday classified a recent product recall announced by Abbott Laboratories ( NYSE: ABT ) for millions of its FreeStyle Libre glucose monitoring systems as a Class I recall, the most serious type. The agency said that Abbott ( ABT ) began...

2023-03-26 12:00:27 ET The market for continuous glucose monitoring systems, where companies such as Abbott Laboratories ( ABT ) and DexCom ( NASDAQ: DXCM ) dominate, is expected to reach $31.7B by 2031, Allied Market Research said in a recent industry report. Rising dia...

2023-03-22 15:31:51 ET Shares of medical device maker Senseonics Holdings ( SENS ) fell ~10% to reach a 52-week low on Wednesday on rising volumes extending its YTD decline to more than 25%. Nearly ~7.4M company shares have changed hands, compared to the 65-day average of ~2.5...

2023-03-15 16:32:16 ET Senseonics press release ( NYSE: SENS ): Q4 GAAP EPS of $0.02 beats by $0.06 . Revenue of $5.6M (+40.0% Y/Y) beats by $0.16M . U.S. revenue was $3.6 million in the fourth quarter of 2022, compared to $0.7 million in the prior year pe...

DexCom ( NASDAQ: DXCM ) added ~7% on Thursday after the Centers for Medicare and Medicaid Services (CMS) updated its policy on continuous glucose monitors to expand coverage for a broader group of diabetes patients. The change, expected to take effect in April, is a “welcom...

Summary Senseonics offers innovative solutions with glucose monitoring systems that provide less invasive alternatives to current devices in the market. The company is expected to see aggressive growth in 2023 despite unimpressive results for the 2022 fiscal year. SENS remains a ver...

Senseonics to report fourth quarter and full year 2022 financial results after market close March 15, 2023 with results to be discussed during the event Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term...

Toronto, Ontario--(Newsfile Corp. - January 19, 2023) - Sensor Technologies Corp. (CSE: SENS) ("Sensor") is pleased to announce that, further to its press releases of December 7, 15 and 16, 2021 and June 6, 2022, it has entered into securities purchase agreements with each of Robotic StemCell Bio...

Summary Inotiv's recently acquired companies cause its revenue to spike tremendously. However, the company's expenses are just as great, and not all of the largest cost items are one-time costs, meaning the company could remain unprofitable for a long time. Specifically, the Goodwil...